MYOBLOC BOTULINUM TOXIN TYPE B INJECTABLE SOLUTION
DEAD

Serial Number

78039531

Owner

SOLSTICE NEUROSCIENCES, INC.

Attorney

LAURA NEWMAN SCIARRINO

First Use Date

Dec 27, 2000

Filing Date

Dec 15, 2000

Add to watchlist:

No watchlists yet
View on USPTO

MYOBLOC BOTULINUM TOXIN TYPE B INJECTABLE SOLUTION Trademark

Serial Number: 78039531 • Registration: 2639583

MYOBLOC BOTULINUM TOXIN TYPE B INJECTABLE SOLUTION is a trademark filed by SOLSTICE NEUROSCIENCES, INC. on December 15, 2000. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

SOLSTICE NEUROSCIENCES, INC. (7 trademarks)

3830 VALLEY CENTRE DR.
SAN DIEGO, CA 92130

Entity Type: 03

ELAN PHARMACEUTICALS, INC. (57 trademarks)

7475 LUSK AVENUE
SAN DIEGO, CA 92121

Entity Type: 03

Trademark Details

Filing Date

December 15, 2000

Registration Date

October 22, 2002

First Use Anywhere

December 27, 2000

First Use in Commerce

December 27, 2000

Published for Opposition

July 30, 2002

Cancellation Date

May 30, 2009

Goods & Services

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Aug 18, 2010 ASCK
CANCELLED SEC. 8 (6-YR)
May 30, 2009 C8..
CASE FILE IN TICRS
Nov 29, 2007 CFIT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 17, 2005 TCCA
REGISTERED-PRINCIPAL REGISTER
Oct 22, 2002 R.PR
PUBLISHED FOR OPPOSITION
Jul 30, 2002 PUBO
NOTICE OF PUBLICATION
Jul 10, 2002 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 1, 2002 CNSA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 24, 2002 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
May 22, 2002 CNSA
EXAMINERS AMENDMENT E-MAILED
May 22, 2002 GNEA
USE AMENDMENT ACCEPTED
May 22, 2002 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Mar 5, 2002 AUPC
USE AMENDMENT FILED
Dec 7, 2001 IUAF
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 7, 2001 CRFA
NON-FINAL ACTION MAILED
Jun 8, 2001 CNRT
ASSIGNED TO EXAMINER
May 10, 2001 DOCK